LICHEN SIMPLEX CHRONICUS
Clinical trials for LICHEN SIMPLEX CHRONICUS explained in plain language.
Never miss a new study
Get alerted when new LICHEN SIMPLEX CHRONICUS trials appear
Sign up with your email to follow new studies for LICHEN SIMPLEX CHRONICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to stop uncontrollable skin itch
Symptom relief OngoingThis study is testing if an injectable medication called dupilumab can reduce severe, persistent itch in adults with Lichen Simplex Chronicus (LSC), a skin condition causing thick, itchy patches. About 142 participants will receive either dupilumab or a placebo injection for 24 w…
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
New injection tested to stop debilitating skin itch
Symptom relief OngoingThis study is testing if dupilumab, given as an injection under the skin, can reduce severe, long-term itching and improve skin appearance in adults with lichen simplex chronicus (LSC). About 138 participants will receive either the study drug or a placebo injection for 24 weeks …
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC